Literature DB >> 26721554

Ayurpharmacoepidemiology en Route to Safeguarding Safety and Efficacy of Ayurvedic Drugs in Global Outlook.

Parikshit Debnath1, Subhadip Banerjee1, Anjan Adhikari2, Pratip K Debnath1.   

Abstract

Ayurpharmacoepidemiology is a new field developed by synergy of the fields of clinical pharmacology, epidemiology, and ayurveda. It will use the effects of ayurvedic medicinal products on large populations to describe and analyze the practices, evaluate the safety and efficacy, and carry out medicoeconomic evaluations. Good pharmacoepidemiology practices in ayurveda is projected to assist with issues of ayurpharmacoepidemiologic research. The embraced good pharmacoepidemiology practices guideline in this viewpoint will be able to provide valuable evidence about the health effects of ayurvedic herbs/drugs and consider different fields like pharmacovigilance, pharmacoeconomics, and drug discovery with ayurvedic reverse pharmacology approach, also pass out significant data for further basic sciences study in ayurveda biology, ayurgenomics, ayurnutrigenomics, and systems biology. Several unanswered questions about ayurvedic drug use and informed interventions or policies that can be addressed by informatics database, which will eventually demonstrate the credibility and rationality of ayurceuticals in the future.

Keywords:  ayurpharmacoepidemiology; ayurvedic herbs/drugs; good pharmacoepidemiology practices in ayurveda; pharmacovigilance

Mesh:

Year:  2016        PMID: 26721554      PMCID: PMC5871175          DOI: 10.1177/2156587215624032

Source DB:  PubMed          Journal:  J Evid Based Complementary Altern Med        ISSN: 2156-5899


  9 in total

Review 1.  Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs.

Authors:  Mahyar Etminan; Ali Samii
Journal:  Pharmacotherapy       Date:  2004-08       Impact factor: 4.705

2.  Pharmacoepidemiological perspectives.

Authors:  U Bergman
Journal:  J Clin Epidemiol       Date:  1992-03       Impact factor: 6.437

3.  Ayurvedic pharmacoepidemiology: a proposed new discipline.

Authors:  Rama A Vaidya; A D B Vaidya; B Patwardhan; G Tillu; Y Rao
Journal:  J Assoc Physicians India       Date:  2003-05

4.  Guidelines for good pharmacoepidemiology practices (GPP).

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-02       Impact factor: 2.890

5.  Use of the UK General Practice Research Database for pharmacoepidemiology.

Authors:  L A García Rodríguez; S Pérez Gutthann
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

Review 6.  An overview of pharmacoepidemiology.

Authors:  A L Wertheimer; K B Andrews
Journal:  Pharm World Sci       Date:  1995-05-26

Review 7.  Role of pharmacoepidemiology in evaluating prescription drug safety in pediatrics.

Authors:  Xuemei Luo; Jim Doherty; Joseph C Cappelleri; Karen Frush
Journal:  Curr Med Res Opin       Date:  2007-11       Impact factor: 2.580

8.  Ayurveda GCP Guidelines: Need for freedom from RCT ascendancy in favor of whole system approach.

Authors:  Bhushan Patwardhan
Journal:  J Ayurveda Integr Med       Date:  2011-01

Review 9.  Ayurnutrigenomics: Ayurveda-inspired personalized nutrition from inception to evidence.

Authors:  Subhadip Banerjee; Parikshit Debnath; Pratip Kumar Debnath
Journal:  J Tradit Complement Med       Date:  2015-03-24
  9 in total
  2 in total

1.  Ayurpharmacoepidemiology Perspective: Health Literacy (Knowledge and Practice) Among Older Diabetes Patients Visiting Ayurveda Teaching Hospitals in India.

Authors:  Parikshit Debnath; Khurshid Natasha; Liaquat Ali; Tapas Bhaduri; Tushar Kanti Roy; Sayantan Bera; Debdeep Mukherjee; Swati Debnath
Journal:  J Evid Based Complementary Altern Med       Date:  2016-07-08

Review 2.  Ayurveda and medicalisation today: The loss of important knowledge and practice in health?

Authors:  Mahesh Madhav Mathpati; Sandra Albert; John D H Porter
Journal:  J Ayurveda Integr Med       Date:  2018-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.